We are urgently seeking 500 new Life Defenders (monthly supporters) before the end of October to help save babies from abortion 365 days a year. Your first gift as a Life Defender today will be DOUBLED. Click here to make your monthly commitment.
The secrecy surrounding the abortion pill’s maker and influential financial investors must end
In part one of this two-part series, Live Action News reported on how the abortion industry is seeking to loosen the way the abortion pill is allowed to be distributed, and is pressuring the FDA to alter its Risk Evaluation Management Strategy (REMS) which currently only allows the abortion pill to be “ordered, prescribed, and dispensed by — or under the supervision of — a hospital or clinic healthcare provider who meets certain qualifications.” The abortion industry is seeking to:
Conduct clinical trials to prove the abortion pill, RU486 – a.k.a. Mifeprex, is safe for pharmacy and mail order dispensing.
Filing lawsuits to force the FDA to remove Mifeprex from REMS.
This is only part of the problem. Another issue is that the abortion pill’s manufacturer itself is incredibly secretive about its stakeholders and controlling parties, which (from the limited information we can glean) appear to stand to gain financially from a broad abortion pill expansion.
Through their Packard Foundation, philanthropists David and Lucile Packard (yes, the ones whose names many have seen in association with supporting public television programming) have been long-time investors in Danco Laboratories, LLC, the company that now manufacturers the abortion pill in the United States. Packard not only helped to seed Danco’s beginning, but also now funds projects that could result in pressuring the FDA to lift important safety regulations so the pill can be sold across multiple online platforms.
Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation)
More conflicts of interest and connections among those pushing this expansion are listed below.
According to the Washington Post (2000), the FDA “took the unprecedented step of refusing to disclose the name or location of the manufacturer” of the abortion pill.
The Washington Post (2000) also reported that the “agency broke with precedent by not publishing the names of the experts who reviewed RU-486 for the agency.”
The LA Times noted (2000), “Danco refuses to release the names of its executives and investors. The company even persuaded the Food and Drug Administration to keep secret the location of the factory where the abortion drug will be produced…. The FDA acceded to Danco’s request that the name of its manufacturer be kept secret — and even shielded the names of the FDA researchers who had overseen the pill’s approval.”
2. The Packard Foundation, a large investor in the abortion pill:
In 1998, Packard seeded DANCO with $10 million. Packard’s investment in the company included a $14 million loan as early as 1996 to bring the drug to the U.S., as well as additional grants made in 2000,2004, and 2009.
The Packard Foundation fundedstudies (in Journal Contraception) that claim self-managed abortion and reversing REMS is safe; the conflict of interest as an abortion pill investor was not noted.
He is a liaison member of Planned Parenthood Federation of America National Medical Committee.
Grossman was a consultant in 2016 for Planned Parenthood Federation of America, providing input on medication abortion (abortion pill) using telemedicine.
The Packard Foundation has funded other Grossman-authored studies.
Abortionist Daniel Grossman (Photo: U of TX Austin)
4. Journal Contraception:
Dear Reader,
Every day in America, more than 2,800 preborn babies lose their lives to abortion.
That number should break our hearts and move us to action.
Ending this tragedy requires daily commitment from people like you who refuse to stay silent.
Millions read Live Action News each month — imagine the impact if each of us took a stand for life 365 days a year.
Right now, we’re urgently seeking 500 new Life Defenders (monthly donors) to join us before the end of October. And thanks to a generous $250,000 matching grant, your first monthly gift will be DOUBLED to help save lives and build a culture that protects the preborn.
Will you become one of the 500 today? Click here now to become a Live Action Life Defender and have your first gift doubled.
Together, we can end abortion and create a future where every child is cherished and every mother is supported.
The Journal and its authors are deeply embedded in the abortion industry.
The Journal published a report claiming there is large public interest in expanding distribution of abortion pill by lifting safety requirements on the drug. See the Live Action News report here.
That study failed to note glaring conflicts of interest, such as the fact that funding came from the David and Lucile Packard Foundation, a major investor in the abortion pill manufacturer, DANCO.
Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception)
5. University of California, San Francisco (UCSF):
Gynuity partners with Packard and the Population Council, both invested in DANCO.
It was founded in 2003 by Beverly Winikoff, M.D. According to Gynuity’s website, Winikoff was employed at the Population Council and served on the board of the National Abortion Federation.
Gynuity funded by population control organizations
An op-ed by Dr. Meera Shah, Associate Medical Director, stated in part, “FDA needs to remove unnecessary requirement for medical providers to supply the mifepristone pill in office, allowing instead pharmacists to dispense it directly.”
Planned Parenthood plan to expand abortion 2019 (Image: screen from PP Action Fund website)
It pushes self-managed abortion, writing, “Given mifepristone’s safety profile, the REMS restrictions are not justified, which is why leading medical organizations such as the American Medical Association (AMA) and the American College of Obstetricians and Gynecologists (ACOG) support lifting the REMS.”
Guttmacher wrote, “clinic-based providers… play a role in supporting people who self-manage,” which “would require payment and reimbursement systems that compensate providers adequately for providing these services…”
Guttmacher has its own abortion expansion plan, previously documented by Live Action News.
9. Advancing New Standards in Reproductive Health (ANSIRH):
ANSIRH published a report with Packard-funded Ibis Reproductive Health and Gynuity Health Projects, suggesting that “medication abortion could be even further demedicalized through pharmacy dispensing and expansion of telemedicine models—or even making it available over the counter (OTC)—which have the potential to expand access greatly.” More here.
Packard, TARA Health, and others funded a National Academy of Sciences review which claimed abortion was safe.
For almost 20 years, with the blessing of the FDA and Clinton Administration at that time, the abortion pill’s manufacturer has been permitted to function in secrecy with its location and investors’ information hidden from the public.
It is past time for the FDA to remove the veil of secrecy from DANCO, so that financially motivated conflicts of interest which corrupt studies on safety can no longer influence the public and pressure regulators to change safety requirements.
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Abortion Pill·By Carole Novielli
